A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer

por Kordes, Sil, Richel, Dick J., Klümpen, Heinz-Josef, Weterman, Mariëtte J., Stevens, Arnoldus J. W. M., Wilmink, Johanna W.
Publicado 2012

Images of God and attitudes towards death in relation to spiritual wellbeing: an exploratory side study of the EORTC QLQ-SWB32 validation study in palliative cancer patients

por Kruizinga, Renske, Scherer-Rath, Michael, Schilderman, Johannes B. A. M., Weterman, Mariëtte, Young, Teresa, van Laarhoven, Hanneke W. M.
Publicado 2017

A phase Ib study of everolimus combined with metformin for patients with advanced cancer

por Molenaar, Remco J., van de Venne, Tim, Weterman, Mariëtte J., Mathot, Ron A., Klümpen, Heinz-Josef, Richel, Dick J., Wilmink, Johanna W.
Publicado 2017

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies

por Deenen, Maarten J., Klümpen, Heinz-Josef, Richel, Dick J., Sparidans, Rolf W., Weterman, Mariette J., Beijnen, Jos H., Schellens, Jan H. M., Wilmink, Johanna W.
Publicado 2011